Additionally, TRUVEN HEALTH MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. Truven Health and GoodRx make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. These products are provided 'AS IS' and 'as available' for use, without warranties of any kind, either express or implied.
The use of the Truven Health products is at your sole risk. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. It is not intended as medical advice for individual conditions or treatment. The information contained in the Truven Health Micromedex products as delivered by GoodRx is intended as an educational aid only. If you are having difficulty accessing this website, please call or email us at (855) 268-2822 or so that we can provide you with the services you require through alternative means. Praxbind (idarucizumab) is a humanized monoclonal antibody fragment (Fab) indicated in patients treated with Pradaxa® (dabigatran) when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding.GoodRx works to make its website accessible to all, including those with disabilities.
Treatment for: Reversal Agent for Pradaxa Last updated by Judith Stewart, BPharm on April 7, 2020.įDA Approved: Yes (First approved October 16, 2015)Ĭompany: Boehringer Ingelheim Pharmaceuticals, Inc.
0 kommentar(er)
